Helicos' Q4 Net Loss Rises on Increased Spending | GenomeWeb

NEW YORK (GenomeWeb News) – Helicos BioSciences' fourth-quarter net loss climbed nearly 50 percent as the firm geared up for the commercial launch of its Helicos Genetic Analysis Platform.

The Cambridge, Mass.-based firm reported that it had grant revenue of $117,000 in the quarter, compared to $159,000 in the fourth quarter of 2006.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.